The Ritz Herald
© DeBio

DeBio Invites Six Advisers to Strengthen Its Bioinformatics Blockchain Product Offering


Published on April 16, 2021

Decentralized Bio Network (DeBio) is a technology startup that utilizes cutting-edge blockchain technology for biomedical testing and bioinformatics analysis. More specifically, genetic testing. DeBio is a privacy-first platform, targeted at privacy-conscious service users.

Pandu Sastrowardoyo, one of the initiators DeBio, has built an advisory committee of very competent individuals from various fields to strengthen their network. The advisors are responsible for providing directions, market reviews, and other considerations in determining and developing potential features of the DeBio service.

The advisory committee will conduct reviews and assessments of features before it is released to consumers. The review and assessment process will also include recommendations for strategic improvements to further improve the product’s quality and robustness.

“These advisors will become part of DeBio who are ready to strengthen the expansion and deepen the genetic and biomedical testing of the DeBio system,” said Ibnu Gamal Alhadid, coordinator of DeBio’s advisory team, added.

Following are the profiles of 6 DeBio advisers:

Dr. Agus Mutamakin, M.Sc.

dr. Mutamakin has 15 years of medical information technology experience as the Chief Information Officer at the National Referral Hospital and as a health information systems consultant. He is also involved in the Data and Information Compartment of the Indonesian Hospital Association and a member of the Health Informatics Technical Committee of the Indonesian National Standard. He has also been invited as a guest lecturer in several master’s degree programs in Hospital Management in Indonesia.

Dr. Hendy Wijaya, M.Biomed

Dr. Wijaya is a researcher specializing in biochemistry, nutrition, and metabolic diseases. He has researched aging, nutrition, metabolic diseases, and genetics. He regularly lectures and teaches biochemistry and physiology on one of the
campuses in Indonesia. He is also a research consultant in a food supplement company.

Karlia Meitha, Ph.D.

Meitha is a researcher adept in the field of molecular biology. She has an interest in genome editing and small RNA applications in the pursuit of a sustainable life. She regularly writes in the field of plant physiology and molecules. Currently, Meitha leads the biotechnology master program to create a generation of biotechnology experts who have creative thinking.

Dr.rer.Nat Marselina Irasonia Tan

Dr. Tan is a researcher specializing in cell and molecular biology, particularly in biomedical sciences. She has research experience in the fields of cancer biology, immunology, and whole-genome sequencing. She is currently active as a lecturer
and regularly lectures about immunology, cell biology, cancer biology, animal development, and tissue engineering.

Popi Septiani, Ph.D.

Septiani is a specialist researcher in the field of genomics and bioinformatics. She has extensive experience in genomic data analysis and transcriptomics in the field of medical and agricultural sciences. She has worked in the field of biotechnology for an agricultural science company. She is currently active as a lecturer, lecturing subjects regarding molecular genetics and bioinformatics in Indonesia’s campuses.

Dr. Theza Pellondo’u, Sp.KF

Dr. Pellondo’u has knowledge and experience in the field of medical forensics, medicolegal, and bioethics. He has helped solve several criminal cases, doctor-patient disputes, and ethical problems in both the fields of medicine and education. He was the Chairman of the Ethics and Legal Committee in a private hospital in Jakarta. He is currently active as the Head of Department and lecturer in forensic medicine and medicolegal, and bioethics at a private medical faculty in Jakarta. He also practices as a forensic and medicolegal specialist in the same city.

Newsroom Editor